Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma

Lung Cancer

Volumn 54, Issue 3, 2006, Pages 409-418

  Kon no, Hidehiro ^a   Ishii, Genichiro ^a   Nagai, Kanji ^a   Yoshida, Junji ^a   Nishimura, Mitsuyo ^a   Nara, Michiya ^a   Fujii, Tomoki ^a   Murata, Yukinori ^a   Miyamoto, Hideaki ^b   Ochiai, Atsushi ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenocarcinoma; Carbonic anhydrase IX; Lung cancer; Prognostic factor

Indexed keywords

CARBONATE DEHYDRATASE IX;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CATALYSIS; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDRATION; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TIME SERIES ANALYSIS; TUMOR GROWTH; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; ANTIGENS, NEOPLASM; CARBONIC ANHYDRASES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 33750366916     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.08.017     Document Type: Article

References (28)

1. Lindskog S. Structure and mechanism of carbonic anhydrase. Pharmacol Ther 74 (1997) 1-20
2. Nógrádi A. The role of carbonic anhydrases in tumors. Am J Pathol 153 (1998) 1-4
3. Parkkila S., Rajaniemi H., Parkkila A.K., Kivela J., and Waheed A. Carbonic anhydrase inhibitor suppresses invasion of renal cancer cells in vitro. PNAS 97 (2000) 2220-2224
4. Pastorek J., Pastorekova S., Callebaut I., Mornon J.P., Zelnik V., Opavsky R., et al. Cloning and characterization of MN, a human tumor-associated protein with a domain domologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene 9 (1994) 2788
5. Wykoff C.C., Beasley N.J.P., Watson P.H., Tuner K.J., Pastorek J., Sibtain A., et al. Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res 60 (2000) 7075-7083
6. Robertson N., Potter C., and Harris A.L. Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer Res 64 (2004) 6160-6165
7. Zavada J., Zavadova Z., Pastorekova S., Ciampor F., Pastorek J., and Zelnik V. Expression of MaTu-MN protein in human tumor cultures and in clinical specimens. Int J Cancer 54 (1993) 268-274
8. Swinson D.E., Jones J.L., Richardson D., Wykoff C., Turley H., Pastorek J., et al. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol 21 (2003) 473-482
9. Kim S.J., Rabbani Z.N., Vollmer R.T., Schreiber E.G., Oosterwijk E., Dewhirst M.W., et al. Carbonic anhydrase IX early-stage non-small cell lung cancer. Clin Cancer Res 10 (2004) 7925-7933
10. Giatromanolaki A., Koukourakis M.I., Sivridis E., Pastorek J., Wykoff C.C., Gatter K.C., et al. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res 61 (2001) 7992-7998
11. Kim S.J., Rabbani Z.N., Dewhirst M.W., Vujaskovic Z., Vollmer R.T., Screiber E.G., et al. Expression of HIF-1α, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer. Lung Cancer 42 (2005) 325-335
12. Simi L., Venturini G., Malentacchi F., Gelmini S., Andreani M., Janni A., et al. Quantitative analysis of carbonic anhydrase IX mRNA in human non-small cell lung cancer. Lung Cancer 52 (2006) 59-66
13. Chia S.K., Wykoff C.C., Watoson P.H., Han C., Leek R.D., Pastorek J., et al. Prognostic significance of a novel hypoxia-regulated marker, carbonic anhydrase IX, in invasive breast carcinoma. J Clin Oncol 16 (2001) 3660-3668
14. Brewer C., Liao S.Y., Wilczynski S.P., Pastorekova S., Pastorek J., Zavada J., et al. A study of biomarkers in cervical carcinoma and clinical correlation of the novel biomarker MN. Gynecol Oncol 63 (1996) 337-344
15. Loncaster J.A., Harris A.L., Davidson S.E., Logue J.P., Hunter R.D., Wycoff C.C., et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia: correlations with tumor oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res 61 (2001) 6394-6399
16. Kim H.L., Seligson D., Liu X., Janzen N., Bui M.H.T., Yu H., et al. Using protein expressions to predict survival in clear cell renal carcinoma. Clin Cancer Res 15 (2004) 5464-5471
17. Pastorekova S., Parkkila S., Parkkila A.K., Opavsky R., Zelnik V., Saarnio J., et al. Carbonic anhydrase IX, MN/CA IX: analysis of stomach complementary DNA sequence and expression in human and rat alimentary tracts. Gastroenterology 112 (1997) 398-408
18. Kivela A.J., Kivela J., Saarnio J., and Parkkila S. Carbonic anhydrases in normal gastrointestinal tract and gastrointestinal tumours. World J Gastroenterol 14 (2005) 155-163
19. Turner J.R., Odze R.D., Crum C.P., and Resnick M.B. MN Antigen expression in normal, preneoplastic, and neoplastic esophagus. Human Pathol 28 (1997) 740-744
20. Saarnio J., Parkkila S., Parkkila A.K., Haukipuro K., Pastoreková S., Pastorek J., et al. Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol 153 (1998) 279-285
21. Liao S.Y., Brewer C., Zavada J., Pastorek J., Pastorekova S., Manetta A., et al. Identification of the MN antigen as a diagnostic biomarker of cervical intraepithelial squamous and glandular neoplasia and cervical carcinoma. Am J Pathol 145 (1994) 598-609
22. Liao S.Y., Aurelio O.N., Jan K., Zavada J., Stanbridge J., et al. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res 57 (1997) 2827-2831
23. Hoogsteen I.J., Marres H.A., Wijffels K.I., Rijken P.F., Peters J.P., Hoogenet F.J., et al. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma. Clin Cancer Res 11 (2005) 97-106
24. Bui M.H., Seligson D., Han K.R., Pantuck A.J., Dorey F.J., Huang Y., et al. Carbonic anhydrase IX Is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy. Clin Cancer Res 9 (2003) 802-811
25. Travis WD, et al. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. WHO Classification of Tumours 2004; 10:26-44.
26. Svastova E., Zilka N., Zatovicova M., Gibadulinova A., Ciampor F., Pastorek J., et al. Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with β-catenin. Exp Cell Res 290 (2003) 332-345
27. Brouwers A.H., Frielink C., Oosterwijk E., Oyen W.J., Corsrens F.H., Boerman O.C., et al. Interferons can upregulate the expression of the tumor associated antigen G250-MN/CA IX, a potential target for (radio)immunotherapy of renal cell carcinoma. Cancer Biother Radiopharmaceut 18 (2003) 539-547
28. Jakubickova L., Biesova Z., Pastorekova S., Kettmann R., and Pastorek J. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines. Int J Oncol 26 (2005) 1121-1127